Interactions between immune cells and microRNAs in tumor microenvironment

No Pathway Network information available for Interactions between immune cells and microRNAs in tumor microenvironment

Pathways in the Interactions between immune cells and microRNAs in tumor microenvironment SuperPath

#	Name	Source	Genes
1	Interactions between immune cells and microRNAs in tumor microenvironment	WikiPathways	CCL2 CCL5 CD274 CD80 CD86 CTLA4 CXCL10 IL2RA IL2RB IL2RG IL4 IL4R IRAK4 MIR138-1 MIR138-2 MIR146A MIR200B MIR200C MIR203A MIR203B MIR21 MIR210 MIR212 MIR214 MIR23A MIR24-1 MIR24-2 MIR27A MIR29A MIR34A MIRLET7D NFKB1 NFKB2 PDCD1 PIAS3 SOCS1 STAT3 STAT6 TGFB1 TGFB2 TGFB3 TGFBR2 TLR4 TLR7 TLR8 TRA TRAF6 TRB (see all 48) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	CD86	CD86 Molecule	Protein Coding	1
2	CD80	CD80 Molecule	Protein Coding	1
3	SOCS1	Suppressor Of Cytokine Signaling 1	Protein Coding	1
4	TRAF6	TNF Receptor Associated Factor 6	Protein Coding	1
5	TLR4	Toll Like Receptor 4	Protein Coding	1
6	TGFBR2	Transforming Growth Factor Beta Receptor 2	Protein Coding	1
7	TGFB3	Transforming Growth Factor Beta 3	Protein Coding	1
8	TGFB2	Transforming Growth Factor Beta 2	Protein Coding	1
9	TGFB1	Transforming Growth Factor Beta 1	Protein Coding	1
10	TRA	T Cell Receptor Alpha Locus	Protein Coding	1
11	STAT6	Signal Transducer And Activator Of Transcription 6	Protein Coding	1
12	STAT3	Signal Transducer And Activator Of Transcription 3	Protein Coding	1
13	CCL5	C-C Motif Chemokine Ligand 5	Protein Coding	1
14	CCL2	C-C Motif Chemokine Ligand 2	Protein Coding	1
15	PDCD1	Programmed Cell Death 1	Protein Coding	1
16	TLR8	Toll Like Receptor 8	Protein Coding	1
17	TLR7	Toll Like Receptor 7	Protein Coding	1
18	IRAK4	Interleukin 1 Receptor Associated Kinase 4	Protein Coding	1
19	NFKB2	Nuclear Factor Kappa B Subunit 2	Protein Coding	1
20	NFKB1	Nuclear Factor Kappa B Subunit 1	Protein Coding	1
21	MIR34A	MicroRNA 34a	RNA Gene	1
22	MIR29A	MicroRNA 29a	RNA Gene	1
23	MIR27A	MicroRNA 27a	RNA Gene	1
24	MIR24-2	MicroRNA 24-2	RNA Gene	1
25	MIR24-1	MicroRNA 24-1	RNA Gene	1
26	MIR23A	MicroRNA 23a	RNA Gene	1
27	MIR214	MicroRNA 214	RNA Gene	1
28	MIR212	MicroRNA 212	RNA Gene	1
29	MIR210	MicroRNA 210	RNA Gene	1
30	MIR21	MicroRNA 21	RNA Gene	1
31	MIR203A	MicroRNA 203a	RNA Gene	1
32	MIR200C	MicroRNA 200c	RNA Gene	1
33	MIR200B	MicroRNA 200b	RNA Gene	1
34	MIR146A	MicroRNA 146a	RNA Gene	1
35	MIR138-1	MicroRNA 138-1	RNA Gene	1
36	MIRLET7D	MicroRNA Let-7d	RNA Gene	1
37	CXCL10	C-X-C Motif Chemokine Ligand 10	Protein Coding	1
38	IL4R	Interleukin 4 Receptor	Protein Coding	1
39	IL4	Interleukin 4	Protein Coding	1
40	IL2RG	Interleukin 2 Receptor Subunit Gamma	Protein Coding	1
41	IL2RB	Interleukin 2 Receptor Subunit Beta	Protein Coding	1
42	IL2RA	Interleukin 2 Receptor Subunit Alpha	Protein Coding	1
43	CD274	CD274 Molecule	Protein Coding	1
44	CTLA4	Cytotoxic T-Lymphocyte Associated Protein 4	Protein Coding	1
45	PIAS3	Protein Inhibitor Of Activated STAT 3	Protein Coding	1
46	TRB	T Cell Receptor Beta Locus	Protein Coding	1
47	MIR138-2	MicroRNA 138-2	RNA Gene	1
48	MIR203B	MicroRNA 203b	RNA Gene	1

Disorders associated with Interactions between immune cells and microRNAs in tumor microenvironment SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Loeys-dietz syndrome	Enrichment	TGFB2, TGFB3, TGFBR2	5.46
2	Systemic lupus erythematosus	Enrichment	CTLA4, PDCD1, SOCS1, TLR7	4.98
3	Loeys-dietz syndrome 4	Enrichment	TGFB2, TGFB3	4.91
4	Anemia, autoimmune hemolytic	Enrichment	SOCS1, TLR8	4.14
5	Immunodeficiency, common variable, 1	Enrichment	CTLA4, NFKB2	4.14
6	Common variable immunodeficiency	Enrichment	NFKB1, NFKB2	3.59
7	Oligoarticular juvenile idiopathic arthritis	Enrichment	IL2RA, IL2RB	3.59
8	Rheumatoid factor-negative juvenile idiopathic arthritis	Enrichment	IL2RA, IL2RB	3.59
9	Familial thoracic aortic aneurysm and aortic dissection	Enrichment	TGFB2, TGFB3, TGFBR2	3.30
10	Marfan syndrome	Enrichment	TGFB2, TGFBR2	3.27
11	Human immunodeficiency virus type 1	Enrichment	CCL2, CCL5	2.74
12	Diffuse large b-cell lymphoma	Enrichment	SOCS1, STAT3	2.70
13	Ehlers-danlos syndrome	Enrichment	TGFB2, TGFBR2	2.70
14	Precursor t-cell acute lymphoblastic leukemia	Enrichment	TRA, TRB	2.53
15	Type 1 diabetes mellitus 10	Enrichment	IL2RA	2.45
16	Celiac disease 3	Enrichment	CTLA4	2.45
17	Hyper-ige syndrome 6, autosomal dominant, with recurrent infections	Enrichment	STAT6	2.45
18	Immunodeficiency 63 with lymphoproliferation and autoimmunity	Enrichment	IL2RB	2.45
19	Immunodeficiency 74, covid19-related, x-linked	Enrichment	TLR7	2.45
20	Autoimmune disease, multisystem, infantile-onset, 4	Enrichment	PDCD1	2.45
21	X-linked immunodeficiency 74	Enrichment	TLR7	2.45
22	Systemic lupus erythematosus 17	Enrichment	TLR7	2.45
23	T-cell large granular lymphocyte leukemia	Enrichment	STAT3	2.45
24	Type 1 diabetes mellitus 12	Enrichment	CTLA4	2.45
25	Camurati-engelmann disease 2	Enrichment	TGFB2	2.45
26	Systemic lupus erythematosus 2	Enrichment	PDCD1	2.45
27	Immunodeficiency 67	Enrichment	IRAK4	2.45
28	Colorectal cancer, hereditary nonpolyposis, type 6	Enrichment	TGFBR2	2.45
29	Macular degeneration, age-related, 10	Enrichment	TLR4	2.45
30	Loeys-dietz syndrome 5	Enrichment	TGFB3	2.45
31	Autoimmune disease, multisystem, infantile-onset, 1	Enrichment	STAT3	2.45
32	Deficiency in anterior pituitary function - variable immunodeficiency syndrome	Enrichment	NFKB2	2.45
33	Autoimmune disease, multisystem, infantile-onset, 5	Enrichment	CD274	2.45
34	Stat3-related early-onset multisystem autoimmune disease	Enrichment	STAT3	2.45
35	Chronic lymphoproliferative disorder of natural killer cells	Enrichment	STAT3	2.45
36	Hashimoto thyroiditis	Enrichment	CTLA4	2.15
37	Camurati-engelmann disease 1	Enrichment	TGFB1	2.15
38	Hemangiopericytoma, malignant	Enrichment	STAT6	2.15
39	Immunodeficiency 33	Enrichment	IRAK4	2.15
40	Immunodeficiency 41 with lymphoproliferation and autoimmunity	Enrichment	IL2RA	2.15
41	Loeys-dietz syndrome 2	Enrichment	TGFBR2	2.15
42	Microvascular complications of diabetes 5	Enrichment	TGFBR2	2.15
43	Immunodeficiency, common variable, 12, with autoimmunity	Enrichment	NFKB1	2.15
44	Immunodeficiency, common variable, 10	Enrichment	NFKB2	2.15
45	Inflammatory bowel disease, immunodeficiency, and encephalopathy	Enrichment	TGFB1	2.15
46	Camurati-engelmann disease	Enrichment	TGFB1	2.15
47	Congenital dyserythropoietic anemia	Enrichment	IRAK4	2.15
48	Trypsinogen deficiency	Enrichment	TRB	2.15
49	Transient predisposition to invasive pyogenic bacterial infection	Enrichment	IRAK4	2.15
50	Common variable immunodeficiency 12	Enrichment	NFKB1	2.15
51	Hyper-ige syndrome 1, autosomal dominant, with recurrent infections	Enrichment	STAT3	1.98
52	Immune thrombocytopenia	Enrichment	SOCS1	1.98
53	Mycosis fungoides	Enrichment	CTLA4	1.98
54	Immunodeficiency 98 with autoinflammation, x-linked	Enrichment	TLR8	1.98
55	Severe combined immunodeficiency, x-linked	Enrichment	IL2RG	1.98
56	Combined immunodeficiency, x-linked	Enrichment	IL2RG	1.98
57	Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation	Enrichment	CTLA4	1.98
58	Autoinflammatory syndrome, familial, with or without immunodeficiency	Enrichment	SOCS1	1.98
59	Breast implant-associated anaplastic large cell lymphoma	Enrichment	STAT3	1.98
60	Hyper ige syndrome	Enrichment	STAT3	1.98
61	Loeys-dietz syndrome 1	Enrichment	TGFBR2	1.98
62	Asparagine synthetase deficiency	Enrichment	CTLA4	1.98
63	Immunodeficiency 7	Enrichment	TRA	1.98
64	Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome	Enrichment	CTLA4	1.98
65	Adult-onset myasthenia gravis	Enrichment	CTLA4	1.98
66	Saczary syndrome	Enrichment	CTLA4	1.98
67	Ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant	Enrichment	TRAF6	1.76
68	Arrhythmogenic right ventricular dysplasia, familial, 1	Enrichment	TGFB3	1.76
69	Vitamin d-dependent rickets, type 2a	Enrichment	TRB	1.76
70	Arrhythmogenic right ventricular dysplasia 1	Enrichment	TGFB3	1.76
71	Atrial septal defect 1	Enrichment	TGFB2	1.68
72	Inflammatory bowel disease 25, autosomal recessive	Enrichment	TGFB1	1.68
73	Granulomatosis with polyangiitis	Enrichment	CTLA4	1.68
74	Il10-related early-onset inflammatory bowel disease	Enrichment	TGFB1	1.68
75	Esophageal cancer	Enrichment	TGFBR2	1.61
76	Permanent neonatal diabetes mellitus	Enrichment	STAT3	1.55
77	Omenn syndrome	Enrichment	IL2RG	1.46
78	Ciliary dyskinesia, primary, 3	Enrichment	NFKB1	1.46
79	Combined immunodeficiency	Enrichment	IL2RG	1.42
80	Ichthyosis	Enrichment	IL2RB	1.42
81	Combined t cell and b cell immunodeficiency	Enrichment	IL2RG	1.42
82	Combined t and b cell immunodeficiency	Enrichment	IL2RG	1.42
83	Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant	Enrichment	TGFB3	1.38
84	Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant	Enrichment	TGFB3	1.38
85	Acute promyelocytic leukemia	Enrichment	STAT3	1.35
86	Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant	Enrichment	TGFB3	1.31
87	Hereditary chronic pancreatitis	Enrichment	TRB	1.31
88	Lynch syndrome	Enrichment	TGFBR2	1.29
89	Pancreatitis, hereditary	Enrichment	TRB	1.23
90	Behcet syndrome	Enrichment	TLR4	1.19
91	Cystic fibrosis	Enrichment	TGFB1	0.97
92	Connective tissue disease	Enrichment	TGFBR2	0.97

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Interactions between immune cells and microRNAs in tumor microenvironment

Pathway Network for Interactions between immune cells and microRNAs in tumor microenvironment

Member Pathways for Interactions between immune cells and microRNAs in tumor microenvironment

Pathways in the Interactions between immune cells and microRNAs in tumor microenvironment SuperPath

Associated Genes for Interactions between immune cells and microRNAs in tumor microenvironment

Associated Disorders for Interactions between immune cells and microRNAs in tumor microenvironment

Disorders associated with Interactions between immune cells and microRNAs in tumor microenvironment SuperPath

STRING Interaction Network for Interactions between immune cells and microRNAs in tumor microenvironment

Sources for Interactions between immune cells and microRNAs in tumor microenvironment